ZA9510447B - Erythromycin derivatives their preparation process and their use as medicaments - Google Patents

Erythromycin derivatives their preparation process and their use as medicaments

Info

Publication number
ZA9510447B
ZA9510447B ZA9510447A ZA9510447A ZA9510447B ZA 9510447 B ZA9510447 B ZA 9510447B ZA 9510447 A ZA9510447 A ZA 9510447A ZA 9510447 A ZA9510447 A ZA 9510447A ZA 9510447 B ZA9510447 B ZA 9510447B
Authority
ZA
South Africa
Prior art keywords
medicaments
preparation process
erythromycin derivatives
formula
erythromycin
Prior art date
Application number
ZA9510447A
Other languages
English (en)
Inventor
Constantin Agouridas
Jean-Francois Chantot
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA9510447B publication Critical patent/ZA9510447B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9510447A 1994-12-09 1995-12-08 Erythromycin derivatives their preparation process and their use as medicaments ZA9510447B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414807A FR2727969B1 (fr) 1994-12-09 1994-12-09 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ZA9510447B true ZA9510447B (en) 1996-12-09

Family

ID=9469625

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9510447A ZA9510447B (en) 1994-12-09 1995-12-08 Erythromycin derivatives their preparation process and their use as medicaments

Country Status (14)

Country Link
US (1) US5786339A (da)
EP (1) EP0716093B1 (da)
JP (1) JP4083824B2 (da)
KR (1) KR100371473B1 (da)
CN (1) CN1067077C (da)
AT (1) ATE172467T1 (da)
AU (1) AU697876B2 (da)
CA (1) CA2164798C (da)
DE (1) DE69505487T2 (da)
DK (1) DK0716093T3 (da)
ES (1) ES2123934T3 (da)
FR (1) FR2727969B1 (da)
HU (1) HU215192B (da)
ZA (1) ZA9510447B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38520E1 (en) * 1996-02-28 2004-05-18 Aventis Pharma S.A. Erythromycin derivatives, method for preparing same, and use thereof as drugs
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE19652362A1 (de) 1996-12-17 1998-06-18 Thomson Brandt Gmbh Verfahren und Vorrichtung zur Kompensation der durch die Verarbeitung von Chrominanz-Signalen entstehenden Luminanzdefekte
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
WO2000017218A1 (en) 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TR200102129T2 (tr) 1998-12-10 2002-01-21 Pfizer Products Inc. Karbamat ve karbazat ketolid antibiyotikleri.
HUP0105190A3 (en) * 1999-01-27 2003-03-28 Pfizer Prod Inc Ketolide antibiotics, medicaments containing them and their use
JP2003500414A (ja) * 1999-05-24 2003-01-07 ファイザー・プロダクツ・インク １３−メチルエリスロマイシン誘導体
WO2001010878A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6183800A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
BRPI0513903A (pt) * 2004-07-28 2008-05-20 Ranbaxy Lab Ltd derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos
EP2233493A1 (en) * 2004-12-21 2010-09-29 Pfizer Products Inc. Macrolides
US10130465B2 (en) 2016-02-23 2018-11-20 Abbott Cardiovascular Systems Inc. Bifurcated tubular graft for treating tricuspid regurgitation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
JPH07219312A (ja) * 1993-12-10 1995-08-18 Canon Inc 画像形成装置

Also Published As

Publication number Publication date
CA2164798C (fr) 2007-03-20
ATE172467T1 (de) 1998-11-15
CA2164798A1 (fr) 1996-06-10
JP4083824B2 (ja) 2008-04-30
HU215192B (hu) 1998-10-28
ES2123934T3 (es) 1999-01-16
DE69505487T2 (de) 1999-05-12
US5786339A (en) 1998-07-28
DE69505487D1 (de) 1998-11-26
FR2727969A1 (fr) 1996-06-14
EP0716093B1 (fr) 1998-10-21
HU9503524D0 (en) 1996-02-28
KR960022553A (ko) 1996-07-18
FR2727969B1 (fr) 1997-01-17
HUT74075A (en) 1996-10-28
DK0716093T3 (da) 1999-06-28
CN1133291A (zh) 1996-10-16
KR100371473B1 (ko) 2003-07-22
JPH08231583A (ja) 1996-09-10
AU697876B2 (en) 1998-10-22
EP0716093A1 (fr) 1996-06-12
CN1067077C (zh) 2001-06-13
AU4032495A (en) 1996-06-20

Similar Documents

Publication Publication Date Title
ZA9510447B (en) Erythromycin derivatives their preparation process and their use as medicaments
ES8404993A1 (es) Procedimiento para preparar derivados de piridina
DE3163871D1 (en) 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
HU9302220D0 (en) Desoxi-taxole derivatives, pharmaceutical preparatives containing them as active agent and methods for producing them
ES8507444A1 (es) Un procedimiento para la preparacion de un derivado de un alcohol , -dihidropoliprenilico
GB1003595A (en) Oral compositions for caries prophylaxis
ES8303279A1 (es) "procedimiento para preparar nuevos derivados de acidos fenil-alifatico-carboxilicos".
ZA876740B (en) Derivatives of 4,5-dihydrooxazoles,a process for their preparation and their use
DE3474298D1 (en) Derivatives of 4-phenyl-4-oxo-buten-2-oic acid, their preparation, medicaments and compositions containing them
DE3165993D1 (en) Salts of endo-8-methyl-8-syn-alkyl-8-azoniabicyclo-(3.2.1)-octane-3-alkylcarboxylates, process for their preparation and therapeutic compositions containing them
DE3475402D1 (en) Endo-8,8-dialkyl-8-azoniabicyclo (3.2.1) octane-6,7-exo-epoxy-3-alkyl-carboxylate salts, a process for their preparation, and therapeutic compositions which contain them as active principle
SU1189337A3 (ru) "cпocoб пoлучehия пpoизboдhыx пиpидилaлkилhиtpatob или иx coлeй c фapmaцebtичeckи пpиemлemыmи kиcлotamи"
NO173278C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 5-androsten-17-on-derivater
GB1313228A (en) Tri-iodo-benzoic acid derivatives
IE810901L (en) Naphthotriazoles.
ES8205816A1 (es) Procedimiento para la preparacion de cardenolido-bis-digoto-xosidos
MY109729A (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
GR851449B (da)
ES8203092A1 (es) Procedimiento para la preparacion de nuevos derivados este- roide-espiro-oxatiazolidinos
AU2742288A (en) Novel compound effective as cerebral insufficiency improver
IL84364A (en) 4-((carboxyalkylthio)-alkenyl)-4-hydroxy-cyclohexanecarboxylic acids,process for their preparation and pharmaceutical compositions containing same
ES8606838A1 (es) Procedimiento para preparar 9-antriloxiaminoalcanos